PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
BRIEF published on 05/06/2025 at 07:35, 1 year 4 months ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
BRIEF published on 05/06/2025 at 07:35, 1 year 4 months ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
BRIEF published on 04/25/2025 at 07:35, 1 year 4 months ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
BRIEF published on 04/25/2025 at 07:35, 1 year 4 months ago Présentation de Sensorion sur la thérapie génique lors de la réunion annuelle de l'ASPO 2025 Essai Clinique Thérapie Génique Perte Auditive SENS-501 Oto-rhino-laryngologie Pédiatrique
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion annonce la participation du Dr. Natalie Loundon à la réunion annuelle de la Société américaine d'oto-rhino-laryngologie pédiatrique pour présenter la thérapie génique SENS-501 pour la perte auditive Thérapie Génique Sensorion Perte Auditive Dr. Natalie Loundon ASPO
BRIEF published on 04/18/2025 at 09:29, 1 year 4 months ago Sensorion prépare son Assemblée générale du 12 mai 2025 Actionnaires Biotechnologie Assemblée Générale Sensorion Perte Auditive
Published on 09/18/2026 at 00:25, 30 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 2 hours 40 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 2 hours 40 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 2 hours 50 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 15:55, 9 hours ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 19:00, 5 hours 54 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 5 hours 56 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 6 hours 29 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 6 hours 44 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 7 hours 8 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 7 hours 15 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/17/2026 at 17:40, 7 hours 15 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
